Hence, a meta-analysis of eligible studies was conducted to determine the association of CYP24A1 expression with the prognosis of cancer patients and the resistance to chemotherapy to clarify the exact prognostic value of CYP24A1 in drug resistance prognosis. This evidence concerns the gene CYP24A1 and cancer.